A detailed history of Alpha Family Trust transactions in Moderna, Inc. stock. As of the latest transaction made, Alpha Family Trust holds 3,990 shares of MRNA stock, worth $213,624. This represents 0.28% of its overall portfolio holdings.

Number of Shares
3,990
Previous 3,990 -0.0%
Holding current value
$213,624
Previous $425,000 11.29%
% of portfolio
0.28%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$69.51 - $104.43 $113,996 - $171,265
1,640 Added 69.79%
3,990 $396,000
Q3 2023

Nov 02, 2023

BUY
$96.41 - $126.61 $50,615 - $66,470
525 Added 28.77%
2,350 $242,000
Q2 2023

Aug 07, 2023

SELL
$118.5 - $160.53 $43,252 - $58,593
-365 Reduced 16.67%
1,825 $221,000
Q4 2022

Feb 08, 2023

BUY
$118.38 - $210.04 $259,252 - $459,987
2,190 New
2,190 $393,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $20.9B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Alpha Family Trust Portfolio

Follow Alpha Family Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Family Trust, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Family Trust with notifications on news.